Tailoring tacrolimus therapy in kidney transplantation.
CONCLUSION: tacrolimus-based immunosuppression is still the best immunosuppressive therapy in kidney transplant recipients, and can be tailored according to patients'need.
PMID: 29779413 [PubMed - as supplied by publisher]
Source: Expert Review of Clinical Pharmacology - Category: Drugs & Pharmacology Tags: Expert Rev Clin Pharmacol Source Type: research
More News: Cytomegalovirus | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Endocrinology | Kidney Transplant | Kidney Transplantation | Prograf | Restasis | Steroid Therapy | Study | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology